Study Finds Digital PCR No Better than Real-Time PCR for Low-Level HIV Detection, Quantification | GenomeWeb

Droplet digital PCR is no better than real-time PCR at detecting and quantifying low levels of cell-associated HIV-1 genetic material from samples taken from patients both on and off antiviral therapy, according to newly published study.

In addition, digital PCR analyses take more time and may be more expensive than real-time PCR for this specific application, said one of the study's authors, who nonetheless also noted that he is "optimistic" about the digital PCR platform — Bio-Rad's QX100 Droplet Digital PCR system — for future similar HIV studies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.